Portal de investigación
ESTUDIO OBSERVACIONAL RETROSPECTIVO SOBRE LA EFECTIVIDAD DE GLIOLAN® EN EL TRATAMIENTO DE LOS GLIOMAS MALIGNOS EN ESPAÑA (ESTUDIO VISIONA).
Datos básicos
- Protocolo:
- GEB-ACA-2011-01
- EUDRACT:
- NO PROCEDE
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
LABORATORIOS GEBRO PHARMA S.A
Resultados del Ensayo Clínico
A gated material as immunosensor for in-tissue detection of IDH1-R132H mutation in gliomas
Pla, L; (...); Martinez-Manez, R
Article. 10.1016/j.snb.2021.130406. 2021
A single center, inter-observer evaluation of vestibular schwannoma stereotactic radiosurgery and its dosimetric impact
Perez-Calatayud, Maria Jose; (...); Perez-Calatayud, Jose
Article. 2024
BCAS1 defines a heterogeneous cell population in diffuse gliomas.
Morales-Gallel, Raquel; (...); Garcia-Verdugo, Jose Manuel
Article. 10.18632/oncotarget.28553. 2024
Intraoperative brain mapping during awake surgery in symptomatic supratentorial cavernomas.
Prat-Acín R; (...); Espert-Tortajada R
Article. 10.1016/j.neucie.2020.07.001. 2021
Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery.
Tejada Solis, Sonia; (...); Prat Acin, Ricardo
Article. 10.1016/j.neucie.2022.11.006. 2022
Septal rhinopharyngeal flap: a novel technique for skull base reconstruction after endoscopic endonasal clivectomies.
Simal-Julian JA; (...); Botella-Asuncion, Carlos
Article. 10.3171/2021.6.JNS203882. 2021
The importance of considering competing risks in recurrence analysis of intracranial meningioma.
Mirian C; (...); Mathiesen T
Article. 10.1007/s11060-024-04572-y. 2024